Best Stocks Under $50 to Buy Today: May 8, 2025
| Number | Ticker | Country | Founded | IPO Year | Price | Revenue | Analyst Decision | Analyst Count |
|---|---|---|---|---|---|---|---|---|
| 1 | United States | 1994 | 2000 | $36.90 | $2,168,701,000.00 | Buy | 18 | |
| 2 | RVLVRevolve Group Inc. | United States | 2003 | 2019 | $17.16 | $1,156,039,000.00 | Buy | 15 |
| 3 | United States | 2007 | 2007 | $22.70 | $154,793,533.00 | Buy | 4 | |
| 4 | United States | 2015 | 2021 | $20.95 | $452,529,000.00 | Buy | 6 | |
| 5 | United States | 2014 | N/A | $37.37 | $1,521,900,000.00 | Buy | 5 | |
| 6 | United States | 2012 | 2012 | $49.84 | $11,409,000,000.00 | Buy | 9 | |
| 7 | United States | 1929 | 2020 | $27.73 | $6,344,000,000.00 | Buy | 15 | |
| 8 | United States | 1992 | 2008 | $12.01 | $144,948,000.00 | Strong Buy | 4 | |
| 9 | United States | 2013 | N/A | $46.62 | $1,550,817,000.00 | Buy | 19 | |
| 10 | United States | 2007 | 2015 | $21.46 | $491,426,000.00 | Strong Buy | 4 | |
| 11 | United States | 1989 | 1990 | $23.10 | $5,802,000,000.00 | Strong Buy | 19 | |
| 12 | United States | 2012 | 2015 | $19.55 | $1,275,000.00 | Strong Buy | 8 | |
| 13 | United States | 1987 | 1989 | $22.16 | $82,254,000.00 | Strong Buy | 7 | |
| 14 | United States | 2015 | 2019 | $35.07 | $127,415,000.00 | Strong Buy | 12 | |
| 15 | United States | 2016 | 2020 | $13.92 | $212,819,000.00 | Strong Buy | 6 | |
| 16 | United States | N/A | N/A | $13.30 | $187,338,000.00 | Strong Buy | 6 | |
| 17 | SRPTSarepta Therapeutics Inc. (DE) | United States | 1980 | 1997 | $36.77 | $2,233,371,000.00 | Buy | 23 |
| 18 | United States | 1999 | N/A | $49.40 | $955,704,000.00 | Buy | 8 | |
| 19 | Chile | 1968 | 1993 | $34.40 | $4,528,761,000.00 | Buy | 7 | |
| 20 | SSTISoundThinking Inc. | United States | 1996 | 2017 | $16.00 | $102,031,000.00 | Buy | 9 |
| 21 | COLDAmericold Realty Trust Inc. | United States | 1903 | 2018 | $17.61 | $2,662,839,000.00 | Buy | 12 |
| 22 | PTCTPTC Therapeutics Inc. | United States | 1998 | 2013 | $42.84 | $1,772,758,000.00 | Buy | 14 |
| 23 | United States | 2013 | 2018 | $33.40 | $347,680,000.00 | Buy | 10 | |
| 24 | United States | 1996 | N/A | $38.90 | $972,179,000.00 | Buy | 8 | |
| 25 | United States | 2017 | 2020 | $17.50 | $63,578,000.00 | Strong Buy | 11 | |
| 26 | LINELINEAGE INC | United States | 2012 | 2024 | $44.93 | $5,302,000,000.00 | Buy | 18 |
| 27 | United States | 1999 | 2000 | $20.28 | $109,112,000.00 | Strong Buy | 5 | |
| 28 | United States | 1992 | 2001 | $25.28 | $1,135,755,000.00 | Buy | 6 | |
| 29 | United Kingdom | 2020 | 2021 | $12.50 | $0.00 | Strong Buy | 9 | |
| 30 | United States | 2001 | 2018 | $17.41 | $1,564,579,000.00 | Buy | 19 | |
| 31 | United States | 2006 | 2011 | $24.97 | $700,966,000.00 | Buy | 9 | |
| 32 | PRMBPrimo Brands Corporation Class A Common Stock | United States | 1955 | N/A | $32.28 | $5,152,500,000.00 | Strong Buy | 6 |
| 33 | United States | 1997 | 2004 | $32.38 | $19,218,000.00 | Buy | 19 | |
| 34 | United States | 2011 | 2018 | $42.14 | $773,996,000.00 | Strong Buy | 21 | |
| 35 | China | 2013 | 2017 | $29.44 | $398,988,000.00 | Buy | 4 | |
| 36 | Switzerland | 2001 | 2021 | $22.78 | $1,145,621,700.00 | Strong Buy | 13 | |
| 37 | United States | 1955 | 1993 | $30.43 | $3,222,363,000.00 | Buy | 5 | |
| 38 | TGTXTG Therapeutics Inc. | United States | 1993 | 1995 | $34.40 | $386,386,000.00 | Strong Buy | 5 |
| 39 | GGenpact Limited | Bermuda | 1997 | 2007 | $42.52 | $4,767,139,000.00 | Buy | 8 |
| 40 | United States | 1999 | 2000 | $27.00 | $2,224,500,000.00 | Buy | 7 | |
| 41 | ENPHEnphase Energy Inc. | United States | 2006 | 2012 | $48.53 | $1,423,128,000.00 | Buy | 29 |
| 42 | United States | 1998 | 2017 | $10.19 | $719,152,000.00 | Buy | 5 | |
| 43 | United States | 1984 | 1994 | $27.03 | $2,422,677,000.00 | Strong Buy | 5 | |
| 44 | United States | 2017 | 2023 | $12.33 | $1,160,881,000.00 | Buy | 8 |
Share on Social Networks:
Disclaimer
The FinQuota filters have identified what they believe to be the "Best Under $50 Stocks to Buy on May 8, 2025" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.